Back
ESC Premium Access

Should we abandon EF to stratify heart failure treatment?

Session: Heart failure with mid-range and preserved ejection fraction
Topic: Miscellaneous
Speaker: Professor S. Solomon (Boston, US)
Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor Scott Solomon

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
65 presentations
22 followers

4 more presentations in this session

State of the Art: HFmrEF - The new middle child

Speaker: Professor R. De Boer (Rotterdam, NL)

Access
Thumbnail

Patterns and prognostic role of N-terminal pro-B-type Natriuretic Peptide in heart failure with mid-range vs. preserved vs. reduced ejection fraction

Speaker: Doctor G. Savarese (Stockholm, SE)

Access
Abstract
Slides
Video
Thumbnail

Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure

Speaker: Doctor A. Aimo (Pisa, IT)

Access
Abstract
Slides
Video
Thumbnail

Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study

Speaker: Doctor M. Gori (Bergamo, IT)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Heart failure with mid-range and preserved ejection fraction

Speakers: Professor S. Solomon, Professor R. De Boer, Doctor G. Savarese, Doctor A. Aimo, Doctor M. Gori
Access
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb